Cell Reprogramming for Regeneration and Repair of the Nervous System

Isaac H. Clark; Alex Roman; Emily Fellows; Swathi Radha; Susanna R. Var; Zachary Roushdy; Samuel M. Borer; Samantha Johnson; Olivia Chen; Jacob S. Borgida; Aleta R Steevens; Anala Shetty; Phoebe Strell; Walter C. Low; Andrew W. Grande

doi:10.3390/biomedicines10102598

Cell Reprogramming for Regeneration and Repair of the Nervous System

Isaac H. Clark, Alex Roman, Emily Fellows, Swathi Radha, Susanna R. Var, Zachary Roushdy, Samuel M. Borer, Samantha Johnson, Olivia Chen, Jacob S. Borgida, Aleta R Steevens, Anala Shetty, Phoebe Strell, Walter C. Low, Andrew W. Grande

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

A persistent barrier to the cure and treatment of neurological diseases is the limited ability of the central and peripheral nervous systems to undergo neuroregeneration and repair. Recent efforts have turned to regeneration of various cell types through cellular reprogramming of native cells as a promising therapy to replenish lost or diminished cell populations in various neurological diseases. This review provides an in-depth analysis of the current viral vectors, genes of interest, and target cellular populations that have been studied, as well as the challenges and future directions of these novel therapies. Furthermore, the mechanisms by which cellular reprogramming could be optimized as treatment in neurological diseases and a review of the most recent cellular reprogramming in vitro and in vivo studies will also be discussed.

Original language	English (US)
Article number	2598
Journal	Biomedicines
Volume	10
Issue number	10
DOIs	https://doi.org/10.3390/biomedicines10102598
State	Published - Oct 2022

Bibliographical note

Funding Information:
This work was funded in part by grants from the State of Minnesota Office of Higher Education, Spinal Cord Injury and Traumatic Brain Injury Research Program, and from the Suzanne M. Schwarz Fund.

Publisher Copyright:
© 2022 by the authors.

Keywords

cell-reprograming
gene therapies
neuro-regeneration

Publisher link

10.3390/biomedicines10102598

Find It

Find It at U of M Libraries

Cite this

@article{6d050f92dbaf41c2b64ae2443a0b8246,

title = "Cell Reprogramming for Regeneration and Repair of the Nervous System",

abstract = "A persistent barrier to the cure and treatment of neurological diseases is the limited ability of the central and peripheral nervous systems to undergo neuroregeneration and repair. Recent efforts have turned to regeneration of various cell types through cellular reprogramming of native cells as a promising therapy to replenish lost or diminished cell populations in various neurological diseases. This review provides an in-depth analysis of the current viral vectors, genes of interest, and target cellular populations that have been studied, as well as the challenges and future directions of these novel therapies. Furthermore, the mechanisms by which cellular reprogramming could be optimized as treatment in neurological diseases and a review of the most recent cellular reprogramming in vitro and in vivo studies will also be discussed.",

keywords = "cell-reprograming, gene therapies, neuro-regeneration",

author = "Clark, {Isaac H.} and Alex Roman and Emily Fellows and Swathi Radha and Var, {Susanna R.} and Zachary Roushdy and Borer, {Samuel M.} and Samantha Johnson and Olivia Chen and Borgida, {Jacob S.} and Steevens, {Aleta R} and Anala Shetty and Phoebe Strell and Low, {Walter C.} and Grande, {Andrew W.}",

note = "Funding Information: This work was funded in part by grants from the State of Minnesota Office of Higher Education, Spinal Cord Injury and Traumatic Brain Injury Research Program, and from the Suzanne M. Schwarz Fund. Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = oct,

doi = "10.3390/biomedicines10102598",

language = "English (US)",

volume = "10",

journal = "Biomedicines",

issn = "2227-9059",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "10",

}

TY - JOUR

T1 - Cell Reprogramming for Regeneration and Repair of the Nervous System

AU - Clark, Isaac H.

AU - Roman, Alex

AU - Fellows, Emily

AU - Radha, Swathi

AU - Var, Susanna R.

AU - Roushdy, Zachary

AU - Borer, Samuel M.

AU - Johnson, Samantha

AU - Chen, Olivia

AU - Borgida, Jacob S.

AU - Steevens, Aleta R

AU - Shetty, Anala

AU - Strell, Phoebe

AU - Low, Walter C.

AU - Grande, Andrew W.

N1 - Funding Information: This work was funded in part by grants from the State of Minnesota Office of Higher Education, Spinal Cord Injury and Traumatic Brain Injury Research Program, and from the Suzanne M. Schwarz Fund. Publisher Copyright: © 2022 by the authors.

PY - 2022/10

Y1 - 2022/10

N2 - A persistent barrier to the cure and treatment of neurological diseases is the limited ability of the central and peripheral nervous systems to undergo neuroregeneration and repair. Recent efforts have turned to regeneration of various cell types through cellular reprogramming of native cells as a promising therapy to replenish lost or diminished cell populations in various neurological diseases. This review provides an in-depth analysis of the current viral vectors, genes of interest, and target cellular populations that have been studied, as well as the challenges and future directions of these novel therapies. Furthermore, the mechanisms by which cellular reprogramming could be optimized as treatment in neurological diseases and a review of the most recent cellular reprogramming in vitro and in vivo studies will also be discussed.

AB - A persistent barrier to the cure and treatment of neurological diseases is the limited ability of the central and peripheral nervous systems to undergo neuroregeneration and repair. Recent efforts have turned to regeneration of various cell types through cellular reprogramming of native cells as a promising therapy to replenish lost or diminished cell populations in various neurological diseases. This review provides an in-depth analysis of the current viral vectors, genes of interest, and target cellular populations that have been studied, as well as the challenges and future directions of these novel therapies. Furthermore, the mechanisms by which cellular reprogramming could be optimized as treatment in neurological diseases and a review of the most recent cellular reprogramming in vitro and in vivo studies will also be discussed.

KW - cell-reprograming

KW - gene therapies

KW - neuro-regeneration

UR - http://www.scopus.com/inward/record.url?scp=85140605777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140605777&partnerID=8YFLogxK

U2 - 10.3390/biomedicines10102598

DO - 10.3390/biomedicines10102598

M3 - Review article

C2 - 36289861

AN - SCOPUS:85140605777

SN - 2227-9059

VL - 10

JO - Biomedicines

JF - Biomedicines

IS - 10

M1 - 2598

ER -

Cell Reprogramming for Regeneration and Repair of the Nervous System

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this